Lymphoma Research: 10 LLS Grants You Should Know

Ines Martins, PhDby Ines Martins, PhD

In Social Clips.

6. MPN Challenge Grant

“The Leukemia & Lymphoma Society (LLS) is partnered with the MPN Research Foundation (MPNRF) to support a grant program whose objective is to change the trajectory and ultimate prognosis for patients with myeloproliferative neoplasms, particularly myelofibrosis, polycythemia vera and essential thrombocythemia. The MPN Challenge program represents an important partnership between LLS and MPNRF, who share a mission to advance the scientific understanding of MPNs and bring new treatments and the hope for a cure to patients with these rare diseases. We anticipate opening the next MPN Challenge grant program in early 2016,” state the LLS.

Find out more here.

7. Transforming CURES Initiative

The Transforming CURES Initiative (TCI) – Intercepting Progression to Advanced Myeloid Blood Cancers is the result of a partnership between the LLS and Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson. The purpose of the grant is to support research able to identify and develop novel, safe and effective treatment paradigms for patients with hematological malignancies, and it consists of $400,000 over a period of three years.

Find out more here.

8. IWMF-LLS Strategic Research Roadmap Initiative

The IWMF-LLS Strategic Research Roadmap Initiative is offered by both the LLS and the International Waldenstrom’s Macroglobulinemia Foundation (IWMF). The initiative is meant to increase knowledge on Waldenstrom’s macroglobulinemia (WM) research, and specifically on the disease’s genomics and epigenomics, signaling, immunology / immunotherapy, and bone marrow / tumor microenvironment.

Find out more here.

Leave a Comment